IL-6 cooperates with peroxisome proliferator-activated receptor-α-ligands to induce liver fatty acid binding protein (LFABP) up-regulation

Liver International

Volumn 33, Issue 7, 2013, Pages 1019-1028

  Vida, Margarita ^a   Serrano, Antonia ^a,e   Romero Cuevas, Miguel ^a   Pavón, Francisco J ^a,e   González Rodriguez, Águeda ^b,c   Gavito, Ana L ^a   Cuesta, Antonio L ^a,d   Valverde, Ángela M ^b,c   Rodríguez de Fonseca, Fernando ^a,e   Baixeras, Elena ^a,d  

^a Laboratorio de Medicina Regenerativa   (Spain)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^e Instituto de Salud Carlos III   (Spain)

Author keywords

GW 6471; Hepatocyte; Interleukin 6; LFABP; Oleoylethanolamide (OEA); PPAR ; WY 14,643

Indexed keywords

FATTY ACID BINDING PROTEIN; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; INTERLEUKIN 6; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

AMPLICON; ANIMAL CELL; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; CORRELATION ANALYSIS; FATTY LIVER; FOOD INTAKE; HEPATOBLASTOMA; HUMAN; HUMAN CELL; LIPID OXIDATION; LIVER CELL; LIVER CELL CULTURE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WILD TYPE;

GW-6471; HEPATOCYTE; INTERLEUKIN 6; LFABP; OLEOYLETHANOLAMIDE (OEA); PPARΑ; WY-14,643;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; DNA PRIMERS; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; GENE EXPRESSION REGULATION; HEP G2 CELLS; HEPATOCYTES; HUMANS; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; PPAR ALPHA; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84880142058     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12156     Document Type: Article

References (32)

1. Newberry EP, Kennedy SM, Xie Y, Luo J, Davidson NO. Diet-induced alterations in intestinal and extrahepatic lipid metabolism in liver fatty acid binding protein knockout mice. Mol Cell Biochem 2009; 326: 79-86.
2. Storch J, McDermott L. Structural and functional analysis of fatty acid-binding proteins. J Lipid Res 2009; 50: S126-31.
3. Akiyama T, Ward JM, Gonzalez FJ. Regulation of the liver fatty acid-binding protein gene by hepatocyte nuclear factor 1a (HNF-1α). J Biol Chem 2000; 275: 27117-22.
4. Khan SH, Sorof S. Liver fatty acid-binding protein: specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators. Proc Natl Acad Sci USA 1994; 91: 848-52.
5. Lawrence JW, Kroll DJ, Eacho PI. Ligand-dependent interaction of hepatic fatty acid-binding protein with the nucleus. J Lipid Res 2000; 41: 1390-1.
6. Kaczocha M, Glaser ST, Deutsch D. Identification of intracellular carriers for the endocannabinoid anandamide. Proc Natl Acad Sci USA 2009; 106: 6375-80.
7. Kaczocha M, Vivieca S, Sun J, Glaser ST, Deutsch DG. Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are Targets of endocannabinoid transport inhibitors. J Biol Chem 2012; 287: 3415-24.
8. Fu J, Gaetani S, Oveisi F, et al. Oleoylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 2003; 425: 90-3.
9. Huang H, Starodub O, McIntosh A, Kier AB, Schroeder F. Liver fatty acid-binding protein targets fatty acids to the nucleus. Real time confocal and multiphoton fluorescence imaging in living cells. J Biol Chem 2002; 277: 29139-51.
10. Hostetler HA, McIntosh AL, Atshaves BP, et al. L-FABP directly interacts with PPARalpha in cultured primary hepatocytes. J Lipid Res 2009; 50: 1663-75.
11. Brandes R, Kaikaus RM, Lysenko N, Ockner RK, Bass NM. Induction of fatty acid binding protein by peroxisome proliferators in primary hepatocyte cultures and its relationship to the induction of peroxisomal beta-oxidation. Biochim Biophys Acta 1990; 23: 53-61.
12. Dubé N, Delvin E, Yotov W, et al. Modulation of intestinal and liver fatty acid-binding proteins in Caco-2 cells by lipids, hormones and cytokines. J Cell Biochem 2001; 81: 613-20.
13. Selzner M, Camargo CA, Clavien PA. Ischemia impairs liver regeneration after major tissue loss in rodents: protective effects of interleukin-6. Hepatology 1999; 30: 469-75.
14. Hong F, Radaeva S, Pan HN, et al. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease. Hepatology 2004; 40: 933-41.
15. Camargo CA Jr, Madden JF, Gao W, Selvan RS, Clavien PA. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997; 26: 513-20.
16. Streetz KL, Tacke F, Leifeld L, et al. Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases. Hepatology 2003; 38: 218-29.
17. Varga T, Czimmerer Z, Nagy L. PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim Biophys Acta 2011; 1812: 1007-22.
18. Rodríguez de Fonseca F, Navarro M, Gómez R, et al. An anorexic lipid mediator regulated by feeding. Nature 2001; 414: 209-12.
19. González-Rodriguez A, Clampit HE, Escribano O, et al. Developmental switch from prolonged insulin action to increased insulin sensitivity in PTP1B-deficient hepatocytes. Endocrinology 2007; 148: 594-608.
20. Zhao S, Fernald RD. Comprehensive algorithm for quantitative real-time polymerase chain reaction. J Comput Biol 2005; 12: 1047-64.
21. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 2007; 8: R19.
22. Lawrence JW, Li Y, Chen S, et al. Differential gene regulation in human vs rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expression. J Biol Chem 2001; 24: 31521-7.
23. Gottlicher M, Widmark E, Li Q, Gustafsson JA. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci USA 1992; 89: 4653-7.
24. Chakravarthy MV, Lodhi IJ, Yin L, et al. Identification of a physiologically relevant endogenous ligand for PPARalpha in liver. Cell 2009; 138: 476-88.
25. Pavon FJ, Serrano A, Romero-Cuevas M, Alonso M, Rodríguez de Fonseca F. Oleoylethanolamide: a new player in peripheral control of energy metabolism. Therapeutic implications. Drug Discovery Today: Disease Mechanisms 2010; 7: e175-83.
26. Keller H, Dreyer C, Medin J, et al. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci U S A 1993; 90: 2160-4.
27. Yanuka-Kashles O, Cohen H, Trus M, et al. Transcriptional regulation of the phosphoenolpyruvate carboxykinase gene by cooperation between hepatic nuclear factors. Mol Cell Biol 1994; 14: 7124-33.
28. Jain S, Li Y, Patil S, Kumar A. HNF-1alpha plays an important role in IL-6-induced expression of the human angiotensinogen gene. Am J Physiol Cell Physiol 2007; 293: C401-10.
29. Fu J, Oveisi F, Gaetani S, Lin E, Piomelli D. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats. Neuropharmacology 2005; 48: 1147-53.
30. Fried SK, Bunkin DA, Greenberg AS Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998; 83: 847-50.
31. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007; 56: 1010-3.
32. Reddy JK, Hashimoto T. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu Rev Nutr 2001; 21: 193-230.